Dartmouth, Canada, July 12, 2010 (ots/PRNewswire) - Ocean Nutrition Canada (ONC) supplier of the most trusted source of Omega-3, EPA/DHA, food and dietary supplement ingredients, announces today the acquisition of the exclusive global marketing and distribution rights to GAT Food Essentials (GAT) ...
Paris, July 12, 2010 (ots/PRNewswire) - Valeo is taking part in the eSafety Challenge 2010 in Millbrook (UK) on July 13, 2010. On this occasion, the Group is presenting a selection of its latest visibility and driving assistance technologies, including advanced lighting and detection systems. In the area of lighting, the new Valeo camera-based ...
Tokyo, July 12, 2010 (ots/PRNewswire) - Daiichi Sankyo Company, Limited announced that its investigational once-daily oral, direct factor Xa inhibitor, edoxaban, was shown to be superior to enoxaparin in preventing venous thromboembolic (VTE) events in patients following total knee replacement (TKR), a type of ...
Institute for Brain and Spinal Cord Disorders (ICM)
Paris, July 8, 2010 (ots/PRNewswire) - Professor Gerard Saillant, President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra. It is the largest single donation made by a private individual to the ICM. Professor Saillant ...
Paris, July 8, 2010 (ots/PRNewswire) - On the occasion of the Haute Couture, Chaumet is putting Tiaras and hair ornaments on the front line for the very first time, at 12, Place Vendome. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/chaumet/44181/ Jewels to be worn on the head that catch the light and embellish the eyes, "Josephine" tiaras, naturalistic headbands, ...
Ottawa, July 8, 2010 (ots/PRNewswire) - The United Nations General Assembly is considering an historic draft resolution recognizing the human right to "safe and clean drinking water and sanitation" initiated by the Bolivian government. Other member states have been consulted on the resolution and the final text is expected to be presented to the President of the General Assembly, for tabling by the end of July. In ...
Dartmouth, Canada, July 6, 2010 (ots/PRNewswire) - Ocean Nutrition Canada Limited - Long time Ocean Nutrition Canada Ltd. (ONC) President and CEO, Robert Orr, will make way for a new CEO to lead the company's next growth phase, with particular focus on international expansion efforts and the food sector. Martin Jamieson, a 30 year international food industry veteran, has been appointed as the new President and ...
Toronto, July 6, 2010 (ots/PRNewswire) - BioHub Inc., announced today the launch of BioHub-Online.org, a first-of- its-kind online platform to facilitate global networking and collaboration among research scientists. Antibodies are biomedical research reagents used for hundreds of thousands of experiments globally. The global market for research antibodies exceeds $2 billion, yet independent studies show that ...
Lugano (ots) - Helsinn's second-generation 5-HT3 RA Aloxi expands its presence in Asia through the Agreement signed with Mundipharma Helsinn Healthcare SA and Mundipharma International Corporation Ltd. announce the signature of a Distribution and Licensing Agreement for Helsinn's product palonosetron in Malesia, Philippines and Singapore. Aloxi® is a ...
New York, July 6, 2010 (ots/PRNewswire) - Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, ...
Monheim, Germany, July 6, 2010 (ots/PRNewswire) - The findings of a landmark Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, showed the remarkable repelling efficacy of Advantix(R) in protecting dogs from ticks and sand flies and thereby reducing the risk of ...
Toronto, July 2, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, France, and Austria, with an option to expand distribution throughout Europe. Under the terms of the agreement, DynamiCARE will pay an initial fee of CDN $2.5 million, with a ...
Castres, France, July 2, 2010 (ots/PRNewswire) - Olivier Bohuon will be replacing Jean-Pierre Garnier as Chief Executive Officer at Pierre Fabre Group starting September 1, 2010. Until now, Olivier Bohuon, 51, was Executive Vice-President of the Abbott Corporation and President of its pharmaceutical division. As such, he ran the group's entire pharmaceutical activities from Chicago ($22 billion in sales). In 2003, he was named the group's President for European ...
Copenhagen, June 30, 2010 (ots/PRNewswire) - The world's most-travelled hot dog stand is in South Africa during the FIFA World Cup 2010 to spread Danish culture and values and to raise money for education of South African bushmen children. The Danish hot dog stand, Hottie, has travelled around the world since 2003. Hottie generates its own electricity with pedal power and through the solar panels on the roof. More ...
Wokingham, England, June 28, 2010 (ots/PRNewswire) - Following an enthusiastic expansion programme into new markets, Kowa Company, Ltd. (President: Yoshihiro Miwa), headquartered in Nagoya, Japan, has granted Abbott, headquartered in Illinois, USA the exclusive license to distribute and market pitavastatin ...
Munich, June 28, 2010 (ots/PRNewswire) - Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate glycemic control on metformin therapy plus diet and exercise. This study found that the addition of ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results up to 76-weeks from a Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy with metformin, which produced long-term glycemic improvement [as measured by glycosylated ...
Ottawa, June 24, 2010 (ots/PRNewswire) - MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers ...
Brussels, June 23, 2010 (ots/PRNewswire) - TechTeam Global, Inc. , a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has won a three-year contract to provide service desk support to Europcar, the European leader in passenger car and light utility vehicle rentals. Under the agreement, ...
Hamburg and Calgary, Canada, June 22, 2010 (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany. The presentation titled "RVX-208 given orally raises ...
Waterford, Ireland, June 22, 2010 (ots/PRNewswire) - A new beginning for Waterford Crystal is marked today with the official opening of the House of Waterford Crystal on the Mall in the heart of Waterford City. The new facility, which comprises manufacturing facility, visitor centre and retail outlet, ensures ...
Oslo, June 21, 2010 (ots/PRNewswire) - Data announced for the first time at ESH suggest that patients with hypertension are at increased cardiovascular risk due to clinician inertia, because physicians are failing to treat targets set by accepted ESH-ESC (European Society of Hypertension and European Society of Cardiology) guidelines for the management of arterial hypertension and do not act soon enough to reduce blood ...
Antony, France, June 21, 2010 (ots/PRNewswire) - Stallergenes S.A. announces the results of a phase III clinical trial (VO55.06) conducted in China aimed at assessing the efficacy and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult patients suffering from asthma triggered by house dust mites. Study VO55.06 is a phase III randomized, ...
Porton Down, England, June 21, 2010 (ots/PRNewswire) - GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to Multiple Sclerosis (MS). Sativex(R) is the world's first prescription cannabis medicine and the UK is the first country in the world to grant a full regulatory authorization ...
Rome, June 19, 2010 (ots/PRNewswire) - /OFF HOLD OFF HOLD OFF HOLD - Servier, PIV395527 The following release: "Protelos(R) (Strontium Ranelate) Builds Stronger Bone Compared to Bisphosphonates" is now OFF HOLD. Distribution time: 19 Jun 2010 08:15 GMT The osteoporosis treatment Protelos(R) (strontium ranelate, Servier) has greater effects than the commonly prescribed bisphosphonate alendronate on bone ...
Basel, Switzerland, June 18, 2010 (ots/PRNewswire) - Roche (SIX: RO, ROG; OTCQX: RHHBY) (http://www.roche.com/investors.htm) today announced that new data being presented at the European League Against Rheumatism (EULAR) congress demonstrates that RoACTEMRA (known as ACTEMRA outside Europe) is highly effective in improving the signs and symptoms of systemic Juvenile ...
Nice, France, June 17, 2010 (ots/PRNewswire) - Medtronic, Inc. today announced European launch of the Protecta(TM) portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The implantable defibrillators feature Medtronic-exclusive SmartShock(TM) ...
St. Petersburg, Russia, June 16, 2010 (ots/PRNewswire) - In 2010, at the St. Petersburg International Economic Forum, leading government officials, business and financial figures, experts and media heads from Russia and across the globe gather to identify and take action on measures to secure the recovery of the global economy while discussing new ideas and solutions to forge more sustainable growth. To view the ...